India
· Delayed Price · Currency is INR Zydus Wellness Statistics
Total Valuation
Zydus Wellness has a market cap or net worth of INR 121.61 billion. The enterprise value is 119.27 billion.
| Market Cap | 121.61B |
| Enterprise Value | 119.27B |
Important Dates
The next estimated earnings date is Friday, February 14, 2025.
| Earnings Date | Feb 14, 2025 |
| Ex-Dividend Date | Jul 19, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 13.89M |
Valuation Ratios
The trailing PE ratio is 38.10.
| PE Ratio | 38.10 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 11.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.40, with an EV/FCF ratio of 32.14.
| EV / Earnings | 37.37 |
| EV / Sales | 4.73 |
| EV / EBITDA | 34.40 |
| EV / EBIT | 36.36 |
| EV / FCF | 32.14 |
Financial Position
The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.26 |
| Quick Ratio | 1.27 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.44 |
| Debt / FCF | 0.42 |
| Interest Coverage | 19.76 |
Financial Efficiency
Return on equity (ROE) is 5.97% and return on invested capital (ROIC) is 3.66%.
| Return on Equity (ROE) | 5.97% |
| Return on Assets (ROA) | 3.46% |
| Return on Capital (ROIC) | 3.66% |
| Revenue Per Employee | 25.00M |
| Profits Per Employee | 3.17M |
| Employee Count | 1,008 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 3.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.10% in the last 52 weeks. The beta is 0.08, so Zydus Wellness's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | +20.10% |
| 50-Day Moving Average | 1,957.04 |
| 200-Day Moving Average | 1,929.17 |
| Relative Strength Index (RSI) | 39.64 |
| Average Volume (20 Days) | 39,646 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zydus Wellness had revenue of INR 25.20 billion and earned 3.19 billion in profits. Earnings per share was 50.16.
| Revenue | 25.20B |
| Gross Profit | 13.09B |
| Operating Income | 3.28B |
| Pretax Income | 3.33B |
| Net Income | 3.19B |
| EBITDA | 3.47B |
| EBIT | 3.28B |
| Earnings Per Share (EPS) | 50.16 |
Balance Sheet
The company has 3.88 billion in cash and 1.54 billion in debt, giving a net cash position of 2.34 billion.
| Cash & Cash Equivalents | 3.88B |
| Total Debt | 1.54B |
| Net Cash | 2.34B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 54.94B |
| Book Value Per Share | 862.26 |
| Working Capital | 6.19B |
Cash Flow
In the last 12 months, operating cash flow was 4.05 billion and capital expenditures -337.00 million, giving a free cash flow of 3.71 billion.
| Operating Cash Flow | 4.05B |
| Capital Expenditures | -337.00M |
| Free Cash Flow | 3.71B |
| FCF Per Share | n/a |
Margins
Gross margin is 51.96%, with operating and profit margins of 13.02% and 12.67%.
| Gross Margin | 51.96% |
| Operating Margin | 13.02% |
| Pretax Margin | 13.23% |
| Profit Margin | 12.67% |
| EBITDA Margin | 13.75% |
| EBIT Margin | 13.02% |
| FCF Margin | 14.73% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.25%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.25% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.96% |
| Buyback Yield | -0.02% |
| Shareholder Yield | 0.23% |
| Earnings Yield | 2.63% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |